Audible and potentially annoying indoor low-frequency noise from a wind farm is present for about 16% of the time at distances up to 3.5km, field data […]
People living with dementia are nine times more likely to be prescribed with the antipsychotic drug risperidone while generally less likely to be given prescribed cardiovascular […]
Point-of-care testing developed at Flinders University will be part of the rollout of new services targeting infectious diseases across remote Australia and also the Asia-Pacific. The […]
Confirmation of 40 new genetic markers takes forward the development of the first tests to assess a person’s risk of developing glaucoma, a leading cause of […]
From diabetes, cancer and heart disease to chronic pain and major depression, 12 new research grants announced today cap off a big year for Flinders medical […]
Flinders University is leading a national program to assist people living with dementia and their carers around Australia. The new Australian Government-funded project, with a $770,517 […]
Leading health and medical researchers at Flinders have secured more than $4.2 million in Australian Government grants.
A national medication study is aiming to help thousands of Australians who struggle every day with shortness of breath.
Vital research into sleep apnoea and IV fluid replacement will receive federal NHMRC funding to help solve leading health problems around the world.